...
首页> 外文期刊>European review for medical and pharmacological sciences. >The impact of preoperative ASA-physical status on postoperative complications and long-term survival outcomes in gastric cancer patients
【24h】

The impact of preoperative ASA-physical status on postoperative complications and long-term survival outcomes in gastric cancer patients

机译:术前ASA的影响在胃癌患者中术后并发症和长期存活结果的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: The aim of this study was to investigate the impact of the preoperative American Society of Anesthesiologists-Physical status (ASA-PS) on both the short-term and long-term outcomes in patients with Gastric Cancer (GC). PATIENTS AND METHODS: In a retrospective observational study, a total of 473 GC patients were divided into the following 3 groups: ASA 1, ASA 2, and ASA 3-4. RESULTS: The ASA 3-4 group included significantly older patients compared to the other groups (p0.0001). In ASA 1 patients, there was a higher number of lymph nodes dissected (p=0.006), and more patients received adjuvant treatment (p0.001). In the three groups, no difference regarding the postoperative surgical and medical complications (p=0.29 and p=0.1, respectively) nor in terms of mortality rate (p=0.17) were demonstrated. The multivariate analysis showed that age, tumor stage, number of lymph nodes dissected, positive lymph nodes, adjuvant treatments, and postoperative surgical complications were significant predictive factors for mortality. Five-year overall and disease-free survival for ASA 1, ASA 2, and ASA 3-4 groups was 56%, 57.6%, and 44%, respectively; and 37%, 44.3%, and 39.2%, respectively. CONCLUSIONS: Preoperative ASA-PS alone cannot serve as a direct operative risk indicator for GC patients.
机译:目的:本研究的目的是调查术前美国麻醉学家身体状况(ASA-PS)对胃癌(GC)患者短期和长期结果的影响。患者和方法:在回顾性观察研究中,共有473名GC患者分为以下3组:ASA 1,ASA 2和ASA 3-4。结果:ASA 3-4组与其他组相比,年龄较大的患者(P <0.0001)。在ASA 1患者中,淋巴结有更多数量的淋巴结(p = 0.006),并且更多患者接受佐剂治疗(P <0.001)。在三组中,对术后手术和医疗并发症(P = 0.29和P = 0.1分别)没有差异,也证明了死亡率(P = 0.17)。多变量分析表明,淋巴结,阳性淋巴结,佐剂治疗和术后外科并发症的年龄,肿瘤阶段,淋巴结数是显着的死亡率的显着预测因素。 ASA 1,ASA 2和ASA 3-4组的五年总体和无病生存率分别为56%,57.6%和44%;分别为37%,44.3%和39.2%。结论:单独的ASA-PS单独不能作为GC患者的直接手术风险指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号